Sichuan Kelun Pharmaceutical Hits Day Low Amid Price Pressure at CNY 31.99

Sichuan Kelun Pharmaceutical Co., Ltd. experienced a notable decline today, with its stock price dropping by 3.22%. The stock reached an intraday low of CNY 31.99, reflecting a challenging trading session. Over the past week, the company has seen a decrease of 4.09%, contrasting with the China Shanghai Composite's decline of 2.93%. In terms of longer-term performance, Sichuan Kelun has shown resilience with a 5.35% increase over the past month, although this is against a backdrop of a 6.21% drop in the broader market index. Year-to-date, the stock has gained 9.4%, significantly outperforming the China Shanghai Composite, which has fallen by 2.01%. Despite these fluctuations, the company has faced challenges, including a 15.48% decline in net sales reported in September. Additionally, the operating cash flow has reached its lowest point at CNY 3,073.46 million, and the return on capital employed stands at 7.2%. With a market capitalization of CNY 36,978 million, Sichuan Kelun remains a significant player in the pharmaceuticals and biotechnology sector.